POTENTIAL FOR PREIMPLANTATION DETERMINATION OF HUMAN PLATELET ANTIGENTYPE USING DNA AMPLIFICATION - A STRATEGY FOR PREVENTION OF ALLO-IMMUNE THROMBOCYTOPENIA
Pr. Bennett et al., POTENTIAL FOR PREIMPLANTATION DETERMINATION OF HUMAN PLATELET ANTIGENTYPE USING DNA AMPLIFICATION - A STRATEGY FOR PREVENTION OF ALLO-IMMUNE THROMBOCYTOPENIA, Fetal diagnosis and therapy, 9(4), 1994, pp. 229-232
To demonstrate that fetal human platelet antigen (HPA1) type can be de
termined by amplification from picogram quantities of DNA, nested olig
onucleotide DNA primers were designed to amplify a portion of the plat
elet glycoprotein GpIIIa gene which spans the polymorphic HPA site. Sp
ecific oligonucleotides were designed to hybridise either to the ampli
fied HPA la allele or to the HPA1b allele. DNA dilutions were used as
a template and HPA1 type, determined by this method from as little as
2 pg of DNA in 6 cases, was compared to direct typing of blood from th
e same individuals. In each case nested polymerase chain reaction ampl
ified the specific HPA locus from as little as 2 pg of DNA and determi
nation of HPA 1 type agreed with typing of blood.